Cytochrome P4502C9 induces cycloxygenase-2 expression in endothelial cells

被引：0
|
作者：
Michaelis, UR [1 ]
Fisslthaler, B [1 ]
Fleming, I [1 ]
Busse, R [1 ]
机构：
[1] Klinikum JWG Univ, Frankfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)93694-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Cytochrome P4502C9 induces cyclo-oxygenase-2 expression in endothelial cells
    Michaelis, UR
    Fisslthaler, B
    Busse, R
    Fleming, I
    HYPERTENSION, 2003, 42 (04) : 628 - 628
  • [2] Effects of avasimibe on cytochrome P4502C9 expression in vitro and in vivo
    Sahi, J
    Stern, RH
    Milad, MA
    Rose, KA
    Gibson, G
    Zheng, XX
    Stilgenbauer, L
    Sadagopan, N
    Jolley, S
    Gilbert, D
    LeCluyse, EL
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) : 1370 - 1376
  • [3] Warfarin dosing and cytochrome P4502C9 polymorphisms
    Joffe, HV
    Xu, RL
    Johnson, FB
    Longtine, J
    Kucher, N
    Goldhaber, SZ
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (06) : 1123 - 1128
  • [4] Allelic and functional variability of cytochrome P4502C9
    Bhasker, CR
    Miners, JO
    Coulter, S
    Birkett, DJ
    PHARMACOGENETICS, 1997, 7 (01): : 51 - 58
  • [5] Clinical consequences of cytochrome P4502C9 polymorphisms
    Kirchheiner, J
    Brockmöller, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) : 1 - 16
  • [6] The Ligands of Estrogen Receptor α Regulate Cytochrome P4502C9 (CYP2C9) Expression
    Mwinyi, Jessica
    Cavaco, Isa
    Yurdakok, Begum
    Mkrtchian, Souren
    Ingelman-Sundberg, Magnus
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01): : 302 - 309
  • [7] Lornoxicam pharmacokinetics in relation to cytochrome P4502C9 genotype
    Zhang, YF
    Zhong, DF
    Si, DY
    Guo, YJ
    Chen, XY
    Zhou, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) : 14 - 17
  • [8] Acenocoumarol pharmacokinetics in relation to cytochrome P4502C9 genotype
    Thijssen, HHW
    Ritzen, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (01) : 61 - 68
  • [9] Pharmacokinetics of glimepiride and cytochrome P4502C9 genetic polymorphisms
    Wang, R
    Chen, K
    Wen, SY
    Li, J
    Wang, SQ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (01) : 90 - 92
  • [10] A global view of cytochrome P4502C9 pharmacogenetics.
    Lanfear, SL
    Van Booven, DJ
    McLeod, HL
    PHARMACOTHERAPY, 2005, 25 (03): : 472 - 473
12345